Canary Capital has made history with the filing of the first-ever staked Injective exchange-traded fund (ETF) with the US Securities and Exchange Commission (SEC). The filing has sent the INJ price on a meteoric rally, with the asset gaining nearly 5% in the last 24 hours. Canary Capital Eyes INJ ETF Approval According to a
The post Just In: Canary Capital Files For First Injective ETF, INJ Price Up appeared first on CoinGape.
